Simon Eccleshall
Latest contributions
Simplify PCI! Know where and how to win with drug-coated balloon
22 May 2025 – From EuroPCR 2025
This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...
When bleeding risk shapes your PCI strategy
05 Jun 2025
Managing ACS in a high-bleeding-risk patient is always a delicate balance. In this case, an 83-year-old with NSTEMI, advanced CKD, and a recent intracranial hemorrhage presented with a complex mid-to-distal LAD lesion. What would be your strategy?
Author
Leave nothing behind - Advancing DCB strategies in complex interventions
18 Dec 2024 – From GulfPCR-GIM 2024
Explore cutting-edge strategies for optimizing drug-coated balloon (DCB) procedures in this session. Uncover practical tips to improve outcomes, review key indications, and examine international consensus on DCB use. Case presentations and expert discussions offer insights to refine your approach.
Mastering the future of PCI with drug-coated balloons
16 May 2024 – From EuroPCR 2024
Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...
The ARC consensus on DCB - evidence-based DCB technology
15 May 2024 – From EuroPCR 2024
In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.
Hotline: new coronary devices (DES, BRS, DCB)
14 May 2024 – From EuroPCR 2024
This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different...
Innovations in coronary disease, diagnosis and treatment
18 May 2023 – From EuroPCR 2023
Join the panelists as they present a series of innovations in coronary disease. Amplify your insight into this vital topic and uncover an array of novelties in diagnosis and treatment.
Current indications for DCB in de novo lesions
18 May 2023 – From EuroPCR 2023
If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...
Latest trends in PCI - Stentless PCI and the role of sustained limus release
17 May 2023 – From EuroPCR 2023
Explore the latest trends in percutaneous coronary intervention (PCI) in this session, focusing on stentless PCI and the role of sustained limus release technology. Join the discussion on how sustained limus release can expand the indications for drug-eluting balloons (DEB) and minimize the use of metal...
Complex coronary artery disease: can stents and DCB be complementary?
16 May 2023 – From EuroPCR 2023
DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
DCB and the possibility of a clean vessel
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...
To stent or not to stent? Discussion of complex PCI cases
26 Jun 2020 – From PCR e-Course 2020
Watch this roundtable discussion if you want to join a detailed discussion about the drug-eluting stent vs. drug-coated balloon approach, to discuss the importance of lesion preparation for optimal coronary intervention results and to share insights about state-of-the-art treatment options from leading expert.
Go implant-free in de novo lesions: DCB-only strategy
22 May 2019 – From EuroPCR 2019
Consult this session to learn about the DCB-only concept, treatment methodology and consensus group recommendations, and discover the latest scientific evidence of DCB-only in de novo lesions and in complex PCIs.
